Multikine Immunotherapy: Cel-Sci Is Weathering The Storm – Seeking Alpha
Seeking Alpha |
Multikine Immunotherapy: Cel-Sci Is Weathering The Storm
Seeking Alpha Head and neck squamous cell carcinoma (HNSCC) accounts for approximately 4% of all cancers in the United States, with 63,000 new diagnosis annually. HNSCC is a disease with high unmet medical needs and a prognosis of a five-year survival due to late … |
